Publications

(2022). In silico studies of natural product-like caffeine derivatives as potential MAO-B inhibitors/AA2AR antagonists for the treatment of Parkinson's disease. Journal Article.
(2022). Structural exploration of selected C6 and C7-substituted coumarin isomers as selective MAO-B inhibitors. Journal Article.